Conclusion.

Event : ESC Congress 2020

• Session : New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients
• Speaker : M Packer (Dallas,US)

• Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

EMPEROR-REDUCED Trial: main results.

Event : ESC Congress 2020

• Session : New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients
• Speaker : M Packer (Dallas,US)

• Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

EMPEROR-Reduced: Empagliflozin in Heart Failure With a Reduced Ejection Fraction, With and Without Diabetes

Event : ESC Congress 2020

• Session : Hot Line EMPEROR-Reduced
• Speaker : M Packer (Dallas,US)

Hot Line EMPEROR-Reduced.

Event : ESC Congress 2020

• Session : Hot Line EMPEROR-Reduced
• Speaker : B Casadei (Oxford,GB), R De Boer (Groningen,NL), M Packer (Dallas,US), M Metra (Brescia,IT)

Panel discussion

Event : ESC Congress 2020

• Session : New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients
• Speaker : G Filippatos (Athens,GR), J Butler (Atlanta,US), M Packer (Dallas,US), S Anker (Berlin,DE), F Zannad (Vandoeuvre,FR)

• Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

The future of pharmacologic treatment of heart failure.

Event : ESC Congress 2020

• Session : New Trial Data in Hypertension and Heart Failure
• Speaker : M Packer (Dallas,US)

Understanding and managing obesity-related HFpEF.

Event : Heart Failure 2019

• Session : Reshaping the future of heart failure management - Translating innovations to practice in HFpEF
• Speaker : M Packer (Dallas,US)

• Organised by PACE-CME - Physicians' Academy for Cardiovascular Education, supported with educational grants provided by Novartis, Novo Nordisk and Pfizer

CANTOS – any word of caution?

Event : ESC Congress 2018

• Session : CANTOS one year after – A critical review: inflammation and CAD prevention
• Speaker : M Packer (Dallas,US)

Case1: my stable Heart Failure with reduced Ejection Fraction (HFrEF) patient: I should start an ARNI immediately!

Event : Heart Failure 2018

• Session : Heart failure case debates with the experts
• Speaker : M Packer (Dallas,US), S Anker (Berlin,DE)

• Organised by Medscape Education, supported with an educational grant by Novartis

Catheter ablation is superior to drugs in the treatment of patients with atrial fibrillation and heart failure - CONTRA

Event : Heart Failure 2018

• Session : GRAND DEBATE I - Drugs or interventions - The beat goes on
• Speaker : M Packer (Dallas,US)

Discussant review - CANTOS.

Event : ESC Congress 2018

• Session : Clinical Trial Updates
• Speaker : M Packer (Dallas,US)

Examining heart failure cases with the experts: challenges faced.

Event : Heart Failure 2018

• Session : Examining heart failure cases with the experts: challenges faced
• Speaker : CS Lam (Singapore,SG), M Packer (Dallas,US), J Cleland (Glasgow,GB)

• Sponsored by Novartis

Heart Failure 10 Years from Now - My predictions and how to get yourself ready.

Event : ESC Congress 2018

• Session : Cardiology 10 years from now - My predictions and how to get yourself ready
• Speaker : M Packer (Dallas,US)

Sacubitril - Valsartan should be the starting treatment in HFrEF patients - PRO

Event : ESC Congress 2018

• Session : First-line therapies in heart failure with reduced ejection fraction (HFrEF) - ACE inhibitors or sacubitril/valsartan?
• Speaker : M Packer (Dallas,US)

• Great Debate

Sacubitril - Valsartan should be the starting treatment in HFrEF patients - Rebuttal PRO

Event : ESC Congress 2018

• Session : First-line therapies in heart failure with reduced ejection fraction (HFrEF) - ACE inhibitors or sacubitril/valsartan?
• Speaker : M Packer (Dallas,US)

• Great Debate

What CABANA and CASTLE-AF do NOT tell us - A critical appraisal

Event : ESC Congress 2018

• Session : Rhythm control therapy in atrial fibrillation - Influence of CASTLE-AF and CABANA on clinical practice in 2018
• Speaker : M Packer (Dallas,US)

A TRUE tale of early vasodilator therapy in acute heart failure.

Event : Heart Failure 2017

• Session : How the results of recent randomized clinical trials will impact our practice
• Speaker : M Packer (Dallas,US)

Henry Krum lecture: what Henry Krum would have thought of the world of heart failure in 2017 .

Event : Heart Failure 2017

• Session : Heart failure management: when the clinician needs advice
• Speaker : M Packer (Dallas,US)

The Effects of Ularitide on the Clinical Course and Cardiovascular mortality in acutely decompensated heart failure depend on the eligibility of patients for the trial: deep-dive results of the TRUE-AHF Trial.

Event : Heart Failure 2017

• Session : Late Breaking Trials I: Focus on acute heart failure
• Speaker : M Packer (Dallas,US)

Vasodilators are useful in the treatment of acute heart failure - CON

Event : ESC Congress 2017

• Session : Are vasodilators useful in the treatment of acute heart failure?
• Speaker : M Packer (Dallas,US)

Vasodilators are useful in the treatment of acute heart failure - Rebuttal CON

Event : ESC Congress 2017

• Session : Are vasodilators useful in the treatment of acute heart failure?
• Speaker : M Packer (Dallas,US)

Vasodilators in acute heart failure: the end of the beginning.

Event : Heart Failure 2017

• Session : Vasodilators in acute heart failure
• Speaker : M Packer (Dallas,US)

Ularatide

Event : ESC Congress 2016

• Session : New drugs in acute heart failure
• Speaker : M Packer (Dallas,US)

From candoxatril to omapatrilat and LCZ696.

Event : ESC Congress 2015

• Session : Natriuretric peptides as a therapeutic approach in chronic and acute heart failure
• Speaker : M Packer (Dallas,US)

PARAMETER: Discussant review.

Event : ESC Congress 2015

• Session : Hot Line IV - Hypertension
• Speaker : M Packer (Dallas,US)

Angiotensin receptor neprilysin inhibitors.

Event : ESC Congress 2014

• Session : Chronic heart failure treatment: what lies ahead
• Speaker : M Packer (Dallas,US)

Dual function molecules in heart failure: what does the future hold?

Event : ESC Congress 2014

• Session : Out with the old and in with the new in heart failure: new insights and new targets
• Speaker : M Packer (Dallas,US)

• Sponsored by Medscape / theheart.org

Panel.

Event : ESC Congress 2014

• Session : PARADIGM-HF: The experts' discussion
• Speaker : JJV McMurray (Glasgow,GB), M Packer (Dallas,US), K Fox (Edinburgh,GB), M Komajda (Paris,FR)

Results of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

Event : ESC Congress 2014

• Session : Hot Line: Cardiovascular disease: novel therapies
• Speaker : M Packer (Dallas,US)

Results of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

Event : ESC Congress 2014

• Session : Meet the Trialist I: PARADIGM-HF
• Speaker : M Packer (Dallas,US)